.. Finale-Étudiée, Population, p.96

O. Mondiale-de and L. Santé, Engagement renouvelé envers l'élimination de la rougeole et de la rubéole et la prévention du syndrome de rubéole congénitale dans la Région européenne de l'OMS d'ici 2015, www.euro.who.int/ 4. International Committee on Taxonomy of Viruses. ICTV. Disponible sur, 2010.

T. Barrett, Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Veterinary Microbiology. 1 sept 1999, pp.3-13

F. Black, Measles endemicity in insular populations: Critical community size and its evolutionary implication, Journal of Theoretical Biology, vol.11, issue.2, pp.207-211, 1966.
DOI : 10.1016/0022-5193(66)90161-5

J. Druelle, Le virus de la rougeole, un système complexe : adaptation, atténuation et modélisation, 2008.

J. Marie, Modulation de la réponse inflammatoire par les protéines du virus de la rougeole

Y. Kerdiles, C. Sellin, J. Druelle, and B. Horvat, Immunosuppression caused by measles virus: role of viral proteins, Reviews in Medical Virology, vol.63, issue.1, pp.49-63, 2006.
DOI : 10.1002/rmv.486

J. Enders and T. Peebles, Propagation in Tissue Cultures of Cytopathogenic Agents from Patients with Measles., Experimental Biology and Medicine, vol.86, issue.2, pp.277-286, 1954.
DOI : 10.3181/00379727-86-21073

M. Kühne, D. Brown, and J. L. , Genetic variability of measles virus in acute and persistent infections, Infection, Genetics and Evolution, vol.6, issue.4, pp.269-276, 2006.
DOI : 10.1016/j.meegid.2005.08.003

O. Mondiale-de and L. Santé, Nomenclature des virus rougeoleux : mise à jour 2012. Relevé épidémiologique hebdomadaire de l'OMS. 2 mars 2012, pp.73-80

W. Moss and G. D. Measles, The Lancet, pp.153-164, 2012.

W. Moss and P. Strebel, Biological Feasibility of Measles Eradication, Journal of Infectious Diseases, vol.204, issue.Supplement 1, pp.47-53, 2011.
DOI : 10.1093/infdis/jir065

T. Hashiguchi, M. Kajikawa, N. Maita, M. Takeda, K. Kuroki et al., Crystal structure of measles virus hemagglutinin provides insight into effective vaccines, Proceedings of the National Academy of Sciences, vol.104, issue.49, pp.19535-19540, 2007.
DOI : 10.1073/pnas.0707830104

W. Xu, A. Tamin, J. Rota, L. Zhang, W. Bellini et al., New genetic group of measles virus isolated in the People's Republic of China, Virus Research, vol.54, issue.2, pp.147-156, 1998.
DOI : 10.1016/S0168-1702(98)00020-3

E. Guide and . Morbillivirus-agent-de-la-rougeole, Disponible sur : http://www.inrs.fr/ 18, Wachtman L, Mansfield K. Chapter Viral Diseases of Nonhuman Primates. Nonhuman Primates in Biomedical Research, vol.2012, pp.1-104

K. Lemon, D. Vries, R. Mesman, A. Mcquaid, S. Van-amerongen et al., Early Target Cells of Measles Virus after Aerosol Infection of Non-Human Primates. Plos Pathog Disponible sur : http://www.plospathogens.org Considering human?primate transmission of measles virus through the prism of risk analysis, American Journal of Primatology, vol.2068, issue.9, pp.868-879, 2006.

O. Mondiale-de and L. Santé, Vaccins contre la rougeole: note d'information de l'OMS. Relevé épidémiologique hebdomadaire de l, OMS, issue.35, pp.349-360, 2009.

L. Ministère-de, . Santé, and . Des-solidarités, Plan d'élimination de la rougeole et de la rubéole congénitale en France, Disponible sur, 2005.

J. Gaudelus, Vaccination contre la rougeole, les oreillons et la rubéole Médecine thérapeutique, Pédiatrie, vol.2, issue.4, pp.273-279, 1999.

R. Anderson and R. May, SUMMARY, Journal of Hygiene, vol.30, issue.02, pp.259-325, 1983.
DOI : 10.1093/ije/9.1.13

URL : https://hal.archives-ouvertes.fr/hal-01407396

M. Choisy, Modélisation mathématique en épidémiologie Écologie de la santé et biodiversité, 2010.

R. Chen, G. Goldbaum, S. Wassilak, L. Markowitz, and W. Orenstein, AN EXPLOSIVE POINT-SOURCE MEASLES OUTBREAK IN A HIGHLY VACCINATED POPULATION, American Journal of Epidemiology, vol.129, issue.1, pp.173-182, 1989.
DOI : 10.1093/oxfordjournals.aje.a115106

D. Kasper, E. Braunwald, A. Fauci, and S. Hauser, Harrisson Principes de Médecine Interne. 16e éd

F. Sillam, P. Strebel, M. Papania, G. Dayan, and M. Halsey, Investigation d'une épidémie de rougeole en région Provence-Alpes-Côte d'Azur et dans la Principauté de Monaco mars-mai 2008. Saint-Maurice: Institut de veille sanitaire Disponible sur : http://opac.invs.sante.fr/ 30, pp.353-398, 2008.

D. Miller, Direction générale de la santé, Comité technique des vaccinations. Guide des vaccinations, Br Med. Bloem MW. Measles blindness. Survey of Ophthalmology. mars, vol.249, issue.322, pp.75-78243, 1963.

R. Barkin, Measles Mortality, American Journal of Diseases of Children, vol.129, issue.3, pp.341-349, 1975.
DOI : 10.1001/archpedi.1975.02120400019004

R. Buchanan and D. Bonthius, Measles Virus and Associated Central Nervous System Sequelae, Seminars in Pediatric Neurology, vol.19, issue.3, pp.107-114, 2012.
DOI : 10.1016/j.spen.2012.02.003

C. Miller, C. Farrington, and K. Harbert, The Epidemiology of Subacute Sclerosing Panencephalitis in England and Wales 1970???1989, International Journal of Epidemiology, vol.21, issue.5, pp.998-1006, 1970.
DOI : 10.1093/ije/21.5.998

B. Tatl?, B. Ekici, and M. Özmen, Current therapies and future perspectives in subacute sclerosing panencephalitis, Expert Review of Neurotherapeutics, vol.12, issue.4, pp.485-492, 2012.
DOI : 10.1586/ern.12.21

M. Chiba, M. Saito, N. Suzuki, Y. Honda, and N. Yaegashi, Measles infection in pregnancy, Journal of Infection, vol.47, issue.1, pp.40-44, 2003.
DOI : 10.1016/S0163-4453(03)00045-8

J. Eberhart-phillips, P. Frederick, R. Baron, and L. Mascola, Measles in pregnancy: A descriptive study of 58 cases, International Journal of Gynecology & Obstetrics, vol.46, issue.1, pp.797-801, 1993.
DOI : 10.1016/0020-7292(94)90321-2

R. Atmar, J. Englund, and H. Hammill, Complications of Measles during Pregnancy, Clinical Infectious Diseases, vol.14, issue.1, pp.217-226, 1992.
DOI : 10.1093/clinids/14.1.217

S. Bar-on, Y. Ochshorn, O. Halutz, Y. Aboudy, and A. Many, Detection of measles virus by reverse-transcriptase polymerase chain reaction in a placenta, The Journal of Maternal-Fetal & Neonatal Medicine, vol.148, issue.8, pp.935-937, 2009.
DOI : 10.3109/14767050903366101

M. Ali and H. Albar, Measles in pregnancy: Maternal morbidity and perinatal outcome, International Journal of Gynecology & Obstetrics, vol.38, issue.(2), pp.109-113, 1997.
DOI : 10.1016/S0020-7292(97)00196-3

G. Ohji, H. Satoh, H. Satoh, K. Mizutani, K. Iwata et al., Congenital measles caused by transplacental infection Direction générale de la santé novembre 2009 relative à la transmission obligatoire de données individuelles à l'autorité sanitaire en cas de rougeole et la mise en oeuvre de mesures préventives autour d'un cas ou de cas groupés. Disponible sur : http://www.sante.gouv.fr/ 45, Diagnostic salivaire de la rougeole et évolution récente des souches virales en France, pp.166-16739, 2009.

R. Helfand, S. Kebede, S. Mercader, H. Gary, H. Beyene et al., The effect of timing of sample collection on the detection of measles-specific IgM in serum and oral fluid samples after primary measles vaccination, Epidemiology and Infection, vol.123, issue.3, pp.451-455, 1999.
DOI : 10.1017/S0950268899002988

M. Riddell, W. Moss, D. Hauer, M. Monze, and D. Griffin, Slow clearance of measles virus RNA after acute infection, Journal of Clinical Virology, vol.39, issue.4, pp.312-317, 2007.
DOI : 10.1016/j.jcv.2007.05.006

D. Griffin, W. Lin, and C. Pan, Measles virus, immune control, and persistence, FEMS Microbiology Reviews, vol.36, issue.3, pp.649-662, 2012.
DOI : 10.1111/j.1574-6976.2012.00330.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319515

. Invs, Confirmation biologique des cas de rougeole Disponible sur

K. Soye, C. Trottier, C. Richardson, B. Ward, and W. Miller, RIG-I Is Required for the Inhibition of Measles Virus by Retinoids, PLoS ONE, vol.137, issue.7, p.22323, 2011.
DOI : 10.1371/journal.pone.0022323.g007

C. Sudfeld, A. Navar, and N. Halsey, Effectiveness of measles vaccination and vitamin A treatment, International Journal of Epidemiology, vol.39, issue.Supplement 1, pp.48-55, 2010.
DOI : 10.1093/ije/dyq021

A. Hinman, F. Zhou, S. Reef, M. Massoudi, M. Papania et al., An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States, Journal of Infectious Diseases. 1 mai, vol.189, pp.131-145, 2004.

M. Choisy, Modélisation mathématique en épidémiologie In: De Boeck, éditeur. Écologie de la santé et biodiversité, 2010.

J. Guthmann and D. Abiteboul, Vaccinations chez les soignants des établissements de soins de France Couverture vaccinale, connaissances et perceptions vis-à-vis des vaccinations, rapport final. Saint-Maurice: Institut de veille sanitaire, 2009.

H. Conseil-de-la-santé-publique, Le Calendrier des vaccinations et les recommandations vaccinales 2012 selon l'avis du Haut Conseil de la santé publique. Bull Épidémiol Hebd, ROUVAX poudre et solvant pour suspension injectable SC IM. Vidal 2012. 57. M-M-RvaxPro® vaccin rougeoleux, des oreillons et rubéoleux (vivant). Vidal 2012. 58. VACCIN PRIORIX® vaccin rougeoleux, des oreillons et rubéoleux vivant, pp.14-15161, 2012.

A. Hinman, M. Dine, S. Hutchins, A. Thomas, I. Williams et al., Persistence of vaccine-induced antibody to measles 26?33 years after vaccination, Journal of Infectious Diseases. 1 mai, vol.189, pp.123-130, 2004.

H. Conseil-de-la-santé-publique, Avis relatif à la problématique de la rougeole chez la femme enceinte 23 mai 2011 Disponible sur : http://www.sante.gouv.fr/ 61. Peltola H, Heinonen O. Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double-blind placebo-controlled trial in twins. The Lancet, pp.939-942, 1986.

H. Conseil-de-la-santé-publique, Avis relatif à l'actualisation des recommandations vaccinales contre la rougeole pour les adultes 11 février 2011, Disponible sur

J. Autret, A. Joinville-bera, C. Galy-eyraud, and L. Hessel, Méningites aseptiques après vaccination anti-ourlienne. Thérapie (Paris), pp.681-684, 1996.

J. Brody, T. Overfield, and L. Hammes, Depression of the Tuberculin Reaction by Viral Vaccines, New England Journal of Medicine, vol.271, issue.25, pp.1294-1296, 1964.
DOI : 10.1056/NEJM196412172712505

J. Stowe, N. Andrews, B. Taylor, and E. Miller, No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine, Vaccine, vol.27, issue.9, pp.1422-1425, 2009.
DOI : 10.1016/j.vaccine.2008.12.038

A. Disponible-sur-wakefield, S. Murch, A. Anthony, J. Linnell, D. Casson et al., RETRACTED: Ileallymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet, pp.637-641, 1998.

K. Madsen, A. Hviid, M. Vestergaard, D. Schendel, J. Wohlfahrt et al., A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism, New England Journal of Medicine, vol.347, issue.19, pp.1477-1482, 2002.
DOI : 10.1056/NEJMoa021134

B. Taylor, Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study, BMJ, vol.324, issue.7334, pp.393-396, 2002.
DOI : 10.1136/bmj.324.7334.393

S. Murch, A. Anthony, D. Casson, M. Malik, M. Berelowitz et al., Retraction of an interpretation, The Lancet, vol.363, issue.9411, p.750, 2004.
DOI : 10.1016/S0140-6736(04)15715-2

S. Plotkin, J. Gerber, P. Offit, A. Henao?restrepo, P. Strebel et al., Vaccines and autism: a tale of shifting hypotheses General Medical Council Dr Andrew Jeremy Wakefield: determination on serious professional misconduct and sanction Disponible sur : http://www.gmc-uk.org/ 73 Experience in global measles control, 74. Centers dor Disease control and Prevention. Progress in global measles control, pp.456-461, 1990.

E. Simons, M. Ferrari, J. Fricks, K. Wannemuehler, A. Anand et al., Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data, The Lancet, vol.379, issue.9832, pp.2173-2178, 2012.
DOI : 10.1016/S0140-6736(12)60522-4

Z. Mihneva, H. Gold, S. Baumgarte, A. Baillot, and R. Helble, World Health Organization, United Nations Children's Fund. Global immunization vision and strategy Switzerland: World Health Organization Disponible sur : http://whqlibdoc.who.int/ 78 Organization; 2010 mars, Organisation Mondiale de la Santé. Bureau régional de l'Europe. Santé 21: introduction à la politique-cadre de la santé pour tous pour la région européenne de l'OMS. Copenhague: OMS, Bureau régional de l'Europe, 1998.

A. Mizrahi and A. Mizrahi, Indicateurs de morbidité et facteurs socio-démographiques, 1985.

R. Sentinelles and I. , Bilans annuels Disponible sur Institut de veille sanitaire (France), Parent Du Châtelet I, Lévy-Bruhl D. Surveillance de la rougeole en France: bilan et évolution en vue de l'élimination de la maladie, 2004.

D. Lévy-bruhl, J. Maccario, S. Richardson, and N. Guérin, Modélisation de la rougeole en France et conséquence pour l'âge d'administration de la seconde vaccination rougeole-oreillons-rubéole

H. Conseil-de-la-santé-publique, Le Calendrier des vaccinations et les recommandations vaccinales 2011 selon l'avis du Haut Conseil de la Santé Publique, Bull Épidémiol Hebd. 22 mars, pp.10-11, 2011.

D. Antona, L. Fonteneau, D. Lévy-bruhl, N. Guignon, D. Peretti et al., Couverture vaccinale des enfants et des adolescents en France : résultats des enquêtes menées en milieu scolaire, Bull Épidémiol Hebd. 13 févr, issue.6, pp.45-49, 2001.

J. Guthmann, L. Fonteneau, D. Lévy-bruhl, S. Mesure-de-la-couverture-vaccinale-en-france-sandier, V. Paris et al., Sources de données et données actuelles Saint-Maurice: Institut de veille sanitaire Disponible sur : http://www.invs.sante.fr/ 96 Systèmes de santé en transition Bureau régional de l'OMS de la part de l'Observatoire européen des systèmes et des politiques de santé Health Systems in Transition, Disponible Chevreul K Health Systems in Transition, vol.12, issue.6, pp.1-291, 2004.

N. Guérin, Vaccination contre la??rougeole: o?? en??sommes-nous en??France en??2006?, Journal de P??diatrie et de Pu??riculture, vol.20, issue.1, pp.1-8, 2006.
DOI : 10.1016/j.jpp.2006.12.001

D. Générale-de and L. Santé, Ministère des Affaires sociales et de la Santé

I. Parent-du-châtelet, D. Antona, D. Waku-kouomou, F. Freymuth, and C. Maine, La rougeole en France en 2008: bilan de la déclaration obligatoire, Bull Épidémiol Hebd. oct, pp.39-40415, 2009.

R. Biellik, C. R. Clements, &. C. Biellik, and . Clements, Strategies for minimizing nosocomial measles transmission Disponible sur : http://apps.who.int, p.54939, 1997.

R. Davis and . Ow, Transmission of Measles in Medical Settings, JAMA, vol.255, issue.10, pp.1295-1298, 1986.
DOI : 10.1001/jama.1986.03370100089023

J. Kremer, F. Schneider, and C. Muller, Waning antibodies in measles and rubella vaccinees???a longitudinal study, Vaccine, vol.24, issue.14, pp.2594-2601, 2006.
DOI : 10.1016/j.vaccine.2005.12.015

K. Glass and B. Grenfell, Waning immunity and subclinical measles infections in England, Vaccine, vol.22, issue.29-30, pp.29-304110, 2004.
DOI : 10.1016/j.vaccine.2004.02.047

M. Evans, Children who miss immunisation: implications for eliminating measles, BMJ, vol.310, issue.6991, pp.1367-1368, 1995.
DOI : 10.1136/bmj.310.6991.1367

J. Li and B. Taylor, Factors affecting uptake of measles, mumps, and rubella immunisation., BMJ, vol.307, issue.6897, pp.168-171, 1993.
DOI : 10.1136/bmj.307.6897.168

N. Gay, The Theory of Measles Elimination: Implications for the Design of Elimination Strategies, The Journal of Infectious Diseases, vol.189, issue.s1, pp.27-35, 2004.
DOI : 10.1086/381592

D. Schmid, H. Holzmann, K. Schwarz, S. Kasper, H. Kuo et al., Measles outbreak linked to a minority group in Austria, 2008, Epidemiology and Infection, vol.11, issue.03, pp.415-425, 2008.
DOI : 10.1136/jech.55.9.685

M. Wadl, A. Siedler, W. Krämer, M. Haindl, S. Gebrande et al., Measles transmission from an anthroposophic community to the general population, Germany 2008, BMC Public Health, vol.189, issue.Suppl 1, p.474, 2008.
DOI : 10.1086/377712

L. Markowitz, A. P. Rhodes, P. Demonteverde, R. Swint, E. Maes et al., Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team, Pediatrics. janv, vol.97, issue.1, pp.53-58, 1996.

E. Leuridan, N. Hens, V. Hutse, M. Ieven, M. Aerts et al., Early waning of maternal measles antibodies in era of measles elimination: longitudinal study, BMJ, vol.340, issue.may18 2, p.1626, 2010.
DOI : 10.1136/bmj.c1626

A. Gagneur, D. Pinquier, A. M. Balu, L. Brissaud, O. Pontual et al., Evolution des anticorps sériques neutralisants anti-rougeole d'origine maternelle chez les nourrissons en france en, pp.225-229, 2006.

J. Mossong, L. Putz, and F. Schneider, Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study, Epidemiology and Infection, vol.132, issue.1, pp.11-18, 2004.
DOI : 10.1017/S0950268803001584

B. Christenson and M. Böttiger, Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus, Vaccine, vol.12, issue.2, pp.129-133, 1994.
DOI : 10.1016/0264-410X(94)90049-3

I. Haralambieva, I. Ovsyannikova, O. Byrne, M. Pankratz, V. Jacobson et al., A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine, Vaccine, vol.29, issue.27, pp.4485-4491, 2011.
DOI : 10.1016/j.vaccine.2011.04.037

J. Mossong, D. Nokes, W. Edmunds, M. Cox, S. Ratnam et al., Modeling the Impact of Subclinical Measles Transmission in Vaccinated Populations with Waning Immunity, American Journal of Epidemiology, vol.150, issue.11, pp.1238-1249, 1999.
DOI : 10.1093/oxfordjournals.aje.a009951

C. Lebaron, J. Beeler, B. Sullivan, B. Forghani, D. Bi et al., Persistence of Measles Antibodies After 2 Doses of Measles Vaccine in a Postelimination Environment, Archives of Pediatrics & Adolescent Medicine, vol.161, issue.3, pp.294-301, 2007.
DOI : 10.1001/archpedi.161.3.294

B. Cohen, S. Audet, N. Andrews, and J. Beeler, Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination, Vaccine, vol.26, issue.1, pp.59-66, 2007.
DOI : 10.1016/j.vaccine.2007.10.046

R. Chen, L. Markowitz, A. P. Stewart, J. Mofenson, L. Preblud et al., Measles Antibody: Reevaluation of Protective Titers, Journal of Infectious Diseases, vol.162, issue.5, pp.1036-1042, 1990.
DOI : 10.1093/infdis/162.5.1036

URL : http://jid.oxfordjournals.org/cgi/content/short/162/5/1036

M. Edmonson, D. Addiss, J. Mcpherson, J. Berg, S. Circo et al., Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population, JAMA. 9 mai, vol.263, issue.18, pp.2467-2471, 1990.

M. Bentley, P. Christian, A. Heath, and W. Unit, Report on collaborative study to investigate the relationship between the 1st IRP and the 2nd and 3rd International Standards for Anti-Measles Serum/Plasma World Health Organization, both ELISA and PRNT, 2007.

B. Cohen, R. Parry, D. Doblas, D. Samuel, L. Warrener et al., Measles immunity testing: Comparison of two measles IgG ELISAs with plaque reduction neutralisation assay, Journal of Virological Methods, vol.131, issue.2, pp.209-212, 2006.
DOI : 10.1016/j.jviromet.2005.08.001

H. Whittle, P. Aaby, B. Samb, H. Jensen, J. Bennett et al., Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa, The Lancet, vol.353, issue.9147, pp.98-102, 1999.
DOI : 10.1016/S0140-6736(98)02364-2

D. Gendrel, M. Chemillier-truong, R. D. , R. J. Bosco, O. Saliou et al., Underestimation of the incidence of measles in a population of french children, European Journal of Clinical Microbiology & Infectious Diseases, vol.78, issue.12, pp.1156-1157, 1992.
DOI : 10.1007/BF01961134

K. Glass and B. Grenfell, Waning immunity and subclinical measles infections in England, Vaccine, vol.22, issue.29-30, pp.29-304110, 2004.
DOI : 10.1016/j.vaccine.2004.02.047

J. Shi, J. Zheng, H. Huang, Y. Hu, J. Bian et al., Measles incidence rate and a phylogenetic study of contemporary genotype H1 measles strains in China: is an improved measles vaccine needed?, Virus Genes, vol.330, issue.Pt1, pp.319-326, 2011.
DOI : 10.1007/s11262-011-0638-0

R. Sanders, A. Dabbagh, and D. Featherstone, Risk Analysis for Measles Reintroduction After Global Certification of Eradication, Journal of Infectious Diseases, vol.204, issue.Supplement 1, pp.71-77, 2011.
DOI : 10.1093/infdis/jir133

L. Ministère-de and . Santé, Étude prospective des métiers sensibles de la fonction publique hospitalière Tome 1, Facteurs d'évolution probables à moyen et long terme dans les champs sanitaire, social et médico-social publics impactant les ressources humaines et les organisations, Rennes: Éd, 2007.

C. Vaccinal, Bull Épidémiol Hebd, pp.29-30211, 2006.

H. Conseil-de-la-santé-publique, Avis relatif au délai à respecter entre l'administration d'immunoglobulines polyvalentes en post-exposition de la rougeole et du vaccin trivalent ROR, Disponible sur, 2002.